Briacell Therapeutics Corp (BCTX) — Cash Flow Quality Index

Latest as of April 2024: -2.94x

Briacell Therapeutics Corp (BCTX) has a Cash Flow Quality Index of -2.94x as of April 2024. Operating cash flow of $-6.78 Million is below net income of $2.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BCTX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-2.94x

Operating CF / Net Income

Operating Cash Flow

$-6.78 Million

USD

Net Income

$2.31 Million

USD

Data as of

Apr 2024

Most recent filing

Annual Cash Flow Quality Index for Briacell Therapeutics Corp (None–None)

Year-by-year earnings quality comparison for Briacell Therapeutics Corp.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.